cyproterone acetate

Ukraine

Drugs containing this active substance

  • ANDROPHARM

    The drug is intended exclusively for men. It is used to reduce libido in cases of sexual deviations, for palliative therapy of inoperable prostate cancer, and at the initial stage to reduce hot flashes caused by high testosterone levels.

    Form: solution for injection

    Active substance Dosage
    cyproterone acetate 100 mg/ml

    ATC: G03HA01

    Manufacturer: Farmak JSC

  • The drug is used by men for palliative therapy of inoperable prostate cancer (specifically to prevent complications from rising testosterone levels and to treat hot flashes). It is also used to reduce libido in cases of hypersexuality and sexual deviations.

    Form: tablets

    Active substance Dosage
    cyproterone acetate 50 mg

    ATC: G03HA01

    Manufacturer: Farmak JSC

  • The drug is used for palliative therapy of inoperable prostate cancer (specifically to prevent complications from rising testosterone levels or to treat hot flashes). It is also prescribed to reduce libido in cases of hypersexuality and sexual deviations.

    Form: tablets

    Active substance Dosage
    cyproterone acetate 100 mg

    ATC: G03HA01

    Manufacturer: Farmak JSC

  • The drug is used for hormone replacement therapy for symptoms of estrogen deficiency during the peri- and postmenopausal periods. It is also used for the prevention of postmenopausal osteoporosis in women at high risk of fractures for whom other treatments are contraindicated.

    Form: tablets, film-coated

    Active substance Dosage
    estradiol valerate 2 mg
    cyproterone acetate 1 mg

    ATC: G03CA53

    Manufacturer: Delpharm Lille SAS

  • The drug is used to treat severe forms of acne (acne vulgaris) and seborrhea, as well as to treat hirsutism (excessive body hair growth) in women of reproductive age. It also acts as a hormonal contraceptive.

    Form: tablets, film-coated

    Active substance Dosage
    ethinylestradiol 0.035 mg
    cyproterone acetate 2 mg

    ATC: G03HB01

    Manufacturer: Bayer AG (primary, secondary packaging, batch release authorization)